• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday

    8/1/23 11:33:39 AM ET
    $AMSC
    $ANET
    $AUDC
    $CAT
    Metal Fabrications
    Consumer Discretionary
    Computer Communications Equipment
    Telecommunications
    Get the next $AMSC alert in real time by email

    U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session.

    • American Superconductor Corporation (NASDAQ:AMSC) jumped 49% to $15.03 amid claims of a new superconductor from a group of physicists.
    • Nikola Corporation (NASDAQ:NKLA) gained 21% to $3.22. The company announced it was awarded an additional $16.3 million to support seven open-network hydrogen refueling stations.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) rose 19% to $21.24 following strong quarterly sales.
    • Arista Networks, Inc. (NYSE:ANET) surged 18.7% to $184.21 after the company reported better-than-expected quarterly results.
    • AudioCodes Ltd. (NASDAQ:AUDC) shares rose 16.2% to $11.66 following upbeat second-quarter earnings.
    • EQRx, Inc. (NASDAQ:EQRX) shares gained 14.3% to $1.9550. Revolution Medicines announced plans to acquire EQRx, Inc. in all-stock transaction.
    • Emergent BioSolutions Inc. (NYSE:EBS) surged 14.2% to $7.86 after the company was awarded a 10-year BARDA contract for development of an Ebola treatment.
    • Proterra Inc. (NASDAQ:PTRA) rose 13.1% to $1.9109.
    • Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) shares gained 10.6% to $9.29 after posting a profit for the second quarter.
    • Mativ Holdings, Inc. (NYSE:MATV) rose 10.3% to $17.36. Mativ reported proposed sale of Engineered Papers business for $620 million.
    • Douglas Dynamics, Inc. (NYSE:PLOW) rose 9.8% to $34.10 following strong quarterly results.
    • TETRA Technologies, Inc. (NYSE:TTI) gained 9.8% to $4.93 after the company posted better-than-expected quarterly results.
    • Varonis Systems, Inc. (NASDAQ:VRNS) gained 9.4% to $31.39 after the company reported second-quarter financial results. Additionally, multiple firms raised their respective price targets on the stock.
    • HUTCHMED (China) Limited (NASDAQ:HCM) jumped 9.2% to $15.36 after the company reported a year-over-year increase in H1 financial results.
    • SunCoke Energy, Inc. (NYSE:SXC) gained 8.8% to $9.66 following strong quarterly results.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) climbed 8.8% to $2.71. Rigetti Computing is expected to report second-quarter results on Aug. 10, 2023.
    • Oshkosh Corporation (NYSE:OSK) rose 8.4% to $99.79 after the company reported better-than-expected second-quarter financial results and issued FY23 guidance.
    • Caterpillar Inc. (NYSE:CAT) gained 7.3% to $284.65 after the company reported better-than-expected second-quarter financial results and issued third-quarter guidance.
    • Global Payments Inc. (NYSE:GPN) rose 6.8% to $117.75 after the company reported strong second-quarter earnings and raised its FY23 guidance.

     

    Read More: This Analyst With 86% Accuracy Rate Sees Around 13% Downside In Intel - Here Are 5 Stock Picks For July From Wall Street's Most Accurate Analysts

    Get the next $AMSC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMSC
    $ANET
    $AUDC
    $CAT

    CompanyDatePrice TargetRatingAnalyst
    Rhythm Pharmaceuticals Inc.
    $RYTM
    2/19/2026$478.00Outperform
    RBC Capital Mkts
    Great Lakes Dredge & Dock Corporation
    $GLDD
    2/12/2026Outperform → Market Perform
    Noble Capital Markets
    Rigetti Computing Inc.
    $RGTI
    2/12/2026Buy → Hold
    TD Cowen
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    Oshkosh Corporation (Holding Company)
    $OSK
    2/3/2026$149.00Underperform → Neutral
    BofA Securities
    Global Payments Inc.
    $GPN
    1/27/2026$80.00Neutral
    Cantor Fitzgerald
    Varonis Systems Inc.
    $VRNS
    1/26/2026$41.00Overweight → Equal-Weight
    Morgan Stanley
    Great Lakes Dredge & Dock Corporation
    $GLDD
    1/22/2026$20.00Overweight
    Analyst
    More analyst ratings

    $AMSC
    $ANET
    $AUDC
    $CAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions Announces New $50 Million Stock Repurchase Program

    GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors authorized the repurchase of up to $50 million of the company's common stock on or before March 31, 2027. This authorization replaces the prior repurchase authorization which permitted Emergent to repurchase up to $50 million of company's common stock by March 27, 2026. Under the prior authorization, Emergent repurchased $24.8 million shares. "In 2025, we were able to return value to shareholders through share repurchases as we continued to make progress on our multi-year transformation," said Joe Papa, president and CEO of Emergent. "This new approval ref

    2/26/26 4:01:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness

    WINNIPEG, Manitoba, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced a series of new contracts and a contract modification with the Public Health Agency of Canada (PHAC) and the Department of National Defence (DND) to deliver critical medical countermeasures to support Canada's biological threat preparedness and response infrastructure. The multiyear agreements, valued at up to approximately $140 million CAD, build upon over a decade of collaboration between Emergent and Canada and reinforce Canada's commitment to long-term readiness and advanced strategic stockpiling. Emergent will receive more than $35M million CAD in orders in 2026. Under these agreeme

    2/26/26 4:01:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMSC
    $ANET
    $AUDC
    $CAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Oliver David R Jr sold $6,820 worth of shares (200 units at $34.10), decreasing direct ownership by 0.33% to 60,707 units (SEC Form 4)

    4 - AMERICAN SUPERCONDUCTOR CORP /DE/ (0000880807) (Issuer)

    2/26/26 5:13:45 PM ET
    $AMSC
    Metal Fabrications
    Consumer Discretionary

    SEC Form 4 filed by Chief Financial Officer Minder Scott

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    2/26/26 5:01:39 PM ET
    $MATV
    Paper
    Basic Materials

    SEC Form 4 filed by President, CEO Singhal Shruti

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    2/26/26 5:01:16 PM ET
    $MATV
    Paper
    Basic Materials

    $AMSC
    $ANET
    $AUDC
    $CAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior Vice President Hardesty Phillip Michael bought $72,872 worth of shares (12,500 units at $5.83), increasing direct ownership by 4% to 298,677 units (SEC Form 4)

    4 - SunCoke Energy, Inc. (0001514705) (Issuer)

    2/26/26 3:02:42 PM ET
    $SXC
    Steel/Iron Ore
    Industrials

    SR VP, Chief Financial Officer Marinko Mark W. bought $58,396 worth of shares (10,000 units at $5.84), increasing direct ownership by 16% to 71,798 units (SEC Form 4)

    4 - SunCoke Energy, Inc. (0001514705) (Issuer)

    2/26/26 3:01:35 PM ET
    $SXC
    Steel/Iron Ore
    Industrials

    Director Johnson Joia M bought $99,345 worth of shares (1,213 units at $81.90), increasing direct ownership by 38% to 4,386 units (SEC Form 4)

    4 - GLOBAL PAYMENTS INC (0001123360) (Issuer)

    2/23/26 5:49:04 PM ET
    $GPN
    Real Estate

    $AMSC
    $ANET
    $AUDC
    $CAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Rhythm Pharmaceuticals with a new price target

    RBC Capital Mkts initiated coverage of Rhythm Pharmaceuticals with a rating of Outperform and set a new price target of $478.00

    2/19/26 7:52:12 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Great Lakes Dredge & Dock downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Great Lakes Dredge & Dock from Outperform to Market Perform

    2/12/26 8:58:11 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    Rigetti Computing downgraded by TD Cowen

    TD Cowen downgraded Rigetti Computing from Buy to Hold

    2/12/26 7:23:36 AM ET
    $RGTI
    EDP Services
    Technology

    $AMSC
    $ANET
    $AUDC
    $CAT
    SEC Filings

    View All

    SEC Form S-3ASR filed by Rhythm Pharmaceuticals Inc.

    S-3ASR - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)

    2/26/26 5:37:52 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Rhythm Pharmaceuticals Inc.

    S-8 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)

    2/26/26 5:16:44 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Rhythm Pharmaceuticals Inc.

    10-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)

    2/26/26 5:02:04 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMSC
    $ANET
    $AUDC
    $CAT
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update

    -- Fourth quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $57.3 million -- -- March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity (HO) ---- Phase 2 open-label extension data showed bivamelagon achieved persistent BMI reductions at six and nine months; Completed positive end-of-Phase-2 meeting with FDA ---- On track to report topline data from 12-patient Japanese cohort of setmelanotide Phase 3 trial in acquired HO in March 2026 -- -- On track to report topline data from Phase 3 EMANATE trial evaluating setmelanotide in rare genetically caused melanocortin-4 receptor (MC4R) pathway diseases in March 2026 -- -- Manag

    2/26/26 7:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH-QUARTER AND STRONG FULL-YEAR 2025 RESULTS AND PROVIDES UPDATE ON STRATEGIC INITIATIVES

    SPRING, Texas, Feb. 25, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and twelve months ended December 31, 2025.Fourth-Quarter 2025 Financial HighlightsRevenues of $146.7 million increased 9% from the fourth quarter of 2024Loss from continuing operations was $15.3 million, inclusive of $18.7 million of unusual chargesLoss per share from continuing operations was $0.11 while Adjusted net income per share was $0.02, excluding unusual chargesAdjusted EBITDA was $20.4 millionNet cash provided by operating activities was $31.7 million - materially above the prior sequential quarter and the fourth quarter of 2024;Adjus

    2/25/26 5:07:00 PM ET
    $TTI
    Oil & Gas Production
    Energy

    $AMSC
    $ANET
    $AUDC
    $CAT
    Leadership Updates

    Live Leadership Updates

    View All

    Global Payments Announces Board Appointment

    Global Payments Inc. (NYSE:GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced the appointment of Vivek Sankaran as a new independent director to the company's Board of Directors, effective February 19, 2026. "Vivek is a terrific addition to our board of directors," said Troy Woods, chair of the Global Payments Board of Directors. "His deep expertise leading technology and digital transformations, as well as his extensive executive experience at some of the most recognizable global brands, will be an invaluable addition to the leadership of this company." "I am delighted to extend a warm welcome to Vivek, an

    2/18/26 7:00:00 AM ET
    $GPN
    Real Estate

    Great Lakes Dredge & Dock to Join the Saltchuk Family of Companies

    HOUSTON and SEATTLE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the "Company") (NASDAQ:GLDD), the largest provider of dredging services in the United States, and Saltchuk Resources, Inc. ("Saltchuk"), a privately owned family of diversified freight transportation, marine service, and energy distribution companies, today announced a definitive agreement for Saltchuk to acquire Great Lakes at an aggregate equity value of approximately $1.2 billion and a total transaction value of $1.5 billion. Under the terms of the agreement, which has been unanimously approved by the Board of Directors of both companies, Saltchuk will commence a tender offer

    2/11/26 7:30:00 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    AudioCodes Expands Its Voice Solution Portfolio for Webex Calling

    AudioCodes now offers an end-to-end portfolio of certified voice solutions for Webex Calling, from Cloud Connect PSTN connectivity to analog gateways and desk phones OR YEHUDA, Israel, Feb. 2, 2026 /PRNewswire/ --  Highlights AudioCodes has expanded its offering of certified solutions for Webex Calling beyond Cloud Connect voice connectivity and SBC solutions with a range of certified IP phones and analog gateways.Three AudioCodes 400HD IP phone models (C450HD, 445HD, 425HD) are now certified for Webex Calling.The secure and robust phones deliver enhanced productivity and collaboration with high-resolution screens, programmable keys and centralized management.AudioCodes IP phones are also

    2/2/26 9:00:00 AM ET
    $AUDC
    Telecommunications Equipment
    Utilities

    $AMSC
    $ANET
    $AUDC
    $CAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Rigetti Computing Inc.

    SC 13G - Rigetti Computing, Inc. (0001838359) (Subject)

    12/5/24 10:15:39 AM ET
    $RGTI
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Rigetti Computing Inc.

    SC 13D/A - Rigetti Computing, Inc. (0001838359) (Subject)

    11/27/24 4:15:57 PM ET
    $RGTI
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Rigetti Computing Inc.

    SC 13D/A - Rigetti Computing, Inc. (0001838359) (Subject)

    11/19/24 7:04:57 PM ET
    $RGTI
    EDP Services
    Technology